Vet Med - Czech, 2017, 62(3):125-130 | DOI: 10.17221/23/2016-VETMED

Efficacy of single-dose ceftriaxone versus multiple-dose enrofloxacin in dogs with uncomplicated lower urinary tract infection: a randomised clinical trialOriginal Paper

E.C. Colakoglu*,1, A.E. Haydardedeoglu2, H. Alihosseini1, A. Hayirli3
1 Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey
2 Faculty of Veterinary Medicine, Aksaray University, Aksaray, Turkey
3 Faculty of Veterinary Medicine, Ataturk University, Erzurum, Turkey

Dogs with uncomplicated lower urinary tract infection (LUTI) are usually treated with appropriate antibiotics for 10-14 days. In humans, a single dose of ceftriaxone is employed in the treatment of uncomplicated LUTI. The purpose of the current study was to compare the efficacy of a single dose of ceftriaxone with multiple dose (14 days) enrofloxacin administration in dogs with uncomplicated LUTI. Forty-seven non-pregnant client-owned dogs with LUTI signs were enrolled in this prospective, controlled, randomised, blinded clinical trial. The inclusion criteria were the presence of at least one type of bacteria greater than or equal to 1000 CFU/ml in each urine sample. Dogs were assigned randomly to Group ENR (n = 23) enrofloxacin treatment (5 mg/kg, s.c., s.i.d., for 14 days) and Group CEF (n = 20) ceftriaxone treatment (25 mg/kg, i.v., once). The time needed for disappearance of clinical signs ranged from 4-9 days and 1-5 days for Group ENR and Group CEF, respectively. Clinical signs significantly improved earlier in Group CEF than in Group ENR (P < 0.0001). Urine culture with less than or equal to 1000 CFU/ml was achieved on Days 17-21 after the first day of treatment in all dogs. Although a single dose of ceftriaxone can be considered as an alternative treatment to alleviate the signs of uncomplicated LUTI in dogs, its status as drug of last resort is a limiting factor for its extensive use in clinical practice.

Keywords: antibiotherapy; canine; haematuria; stranguria; urine

Published: March 31, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Colakoglu EC, Haydardedeoglu AE, Alihosseini H, Hayirli A. Efficacy of single-dose ceftriaxone versus multiple-dose enrofloxacin in dogs with uncomplicated lower urinary tract infection: a randomised clinical trial. Vet Med - Czech. 2017;62(3):125-130. doi: 10.17221/23/2016-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arav-Boger R, Leibovici L, Danon YL (1994): Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment. Archives of Internal Medicine 154, 300-304. Go to original source...
    2. Ball KR, Rubin JE, Dowling PM (2008): Antimicrobial resistance and prevalence of canine uropathogens at the Western College of Veterinary Medicine Veterinary Teaching Hospital. Canadian Veterinary Journal 49, 985-990.
    3. Bartges JW (2004): Diagnosis of urinary tract infections. Veterinary Clinics of North America: Small Animal Practice 34, 923-933. Go to original source... Go to PubMed...
    4. Bleidorn J, Gagyor I, Kochen MM, Wegscheider K, Hummers-Pradier E (2010): Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? Results of a randomized controlled pilot trial. BMC Medicine 8, 30. Go to original source... Go to PubMed...
    5. Chew DJ, DiBartola SP, Schenck P (eds) (2011): Canine and Feline Nephrology and Urology. 2nd edn. Elsevier, St Louis. 526 pp.
    6. Clare S, Hartmann FA, Jooss M, Bachar E, Wong YY, Trepanier LA, Viviano KR (2014): Short- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole treatment in female dogs with uncomplicated bacterial cystitis. Journal of Veterinary Internal Medicine 28, 818-826. Go to original source... Go to PubMed...
    7. Cohn LA, Gary AT, Fales WH, Madsen RW (2003): Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. Journal of Veterinary Diagnostic Investigation 15, 338-343. Go to original source... Go to PubMed...
    8. Cooke CL, Singer RS, Jang SS, Dwight BA, Hirsh C (2002): Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. Journal of American Veterinary Medical Association 220, 190-192. Go to original source... Go to PubMed...
    9. Ettinger SJ, Feldman EC (eds) (2010): Textbook of Veterinary Internal Medicine. 7th edn. Elsevier. 1965 pp.
    10. Grauer GF (2009): Urinary tract infections. In: Nelson RW, Couto CG (eds): Small Animal Internal Medicine. 4th edn. Elsevier. 664-665.
    11. Iravani A, Richard GA (1985): Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections. Antimicrobial Agents and Chemotherapy 27, 158-161. Go to original source... Go to PubMed...
    12. Lin HA, Yang YS, Wang JX, Lin HC, Lin DY, Chiu CH, Yeh KM, Lin JC, Chang FY (2016): Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. Journal of Microbiology, Immunology, and Infection 49, 237-242. Go to original source... Go to PubMed...
    13. Ling GV, Norris CR, Franti CE, Eisele PH, Johnson DL, Ruby AL, Jang SS (2001): Interrelations of organism prevalence, specimen collection method, and host age, sex, and breed among 8,354 canine urinary tract infections (1969-1995). Journal of Veterinary Internal Medicine 15, 341-347. Go to original source...
    14. Meyers BR, Srulevitch ES, Jacobson J, Hirschman SZ (1983): Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers. Antimicrobial Agents and Chemotherapy 24, 812-814. Go to original source... Go to PubMed...
    15. Moller NF (2002): Correlation between pharmacokinetic/ pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. International Journal of Antimicrobial Agents 19, 546-553. Go to original source... Go to PubMed...
    16. Nicholle LE (2002): Urinary tract infection: traditional pharmacologic therapies. American Journal of Medicine 1, 35-44. Go to original source... Go to PubMed...
    17. Park DW, Peck KR, Chung MH, Lee JS, Park YS, Kim HY, Lee MS, Kim JY, Yeom JS, Kim MJ (2012): Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: A randomized, double blind multicenter trial. Journal of Korean Medical Science 27, 476- 483. Go to original source... Go to PubMed...
    18. Passmore CA, Sherington J, Stegemann MR (2007): Efficacy and safety of cefovecin (convenia) for the treatment of urinary tract infections in dogs. Journal of Small Animal Practice 48, 139-144. Go to original source... Go to PubMed...
    19. Polzin DJ (1999): Therapy of canine and feline urinary tract infections with enrofloxacin. Compendium on Continuing Education Practicing Veterinarian 21, 65-72.
    20. Rebuelto M, Albarellos G, Ambros L, Kreil V, Montoya L, Bonafine R, Otero P, Hallu R (2002): Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs. Journal of Veterinary Pharmacology and Therapeutics 25, 73-76. Go to original source... Go to PubMed...
    21. Ringger NC, Pearson EG, Gronwall RR, Kohlepp SJ (1996): Pharmacokinetics of ceftriaxone in healthy horses. Equine Veterinary Journal 26, 476-479. Go to original source... Go to PubMed...
    22. Ringger NC, Brown MP, Kohlepp SJ, Gronwall RR, Merritt K (1998): Pharmaco-kinetics of ceftriaxone in neonatal foals. Equine Veterinary Journal 30, 163-165. Go to original source... Go to PubMed...
    23. Rodman DP, Mcknight JT, Anderson RL (1994): A critical review of the new oral cephalosporins. Considerations and place in therapy. Archives of Family Medicine 3, 975-980. Go to original source... Go to PubMed...
    24. Seguin MA, Vaden SL, Altier C, Stone E, Levine JF (2003): Persistent urinary tract infections and reinfections in 100 dogs (1989-1999). Journal of Veterinary Internal Medicine 17, 622-631. Go to original source...
    25. Soback S, Ziv G (1988): Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves. American Journal of Veterinary Research 49, 535-538.
    26. Weese JS, Blondeau JM, Boothe D, Breitschwerdt EB, Guardabassi L, Hillier A, Lloyd DH, Papich MG, Rankin SC, Turnidge JD, Sykes JE (2011): Antimicrobial use guidelines for treatment of urinary tract disease in dogs and cats: Antimicrobial guidelines working group of the international society for companion animal infectious diseases. Veterinary Medicine International, doi: 10.4061/2011/263768. Go to original source... Go to PubMed...
    27. Westropp JL, Sykes JE, Irom S, Daniels JB, Smith A, Keil D, Settje T, Wang Y, Chew DJ (2012): Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs. Journal of Veterinary Internal Medicine 26, 506-512. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content